Pharma sector may see mixed operating performance in 3QFY14E: Kotak Institutional Equities
Expects core profit growth of over 15 per cent y-o-y
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Novel osteoporosis drug could change treatment: Study
The treatment is one-and-a-half to three times more effective than current osteoporosis drugs in rebuilding bone density at the…
Prognosis for 2014: Healthy but regulatory reform remains a concern
The last month of 2013 had a significant number of fairly high profile, high value private equity (PE) deals focused on the…
January 1-15, 2014
{source}<div data-configid="5690019/6170379" style="width: 600px; height: 402px;" class="issuuembed"></div><script…
Venus Medicine Research Centre, Baba Farid varsity sign MoU on research
To undertake collaborative research projects, academic programmes, open new frontiers for high-end research in India in oncology,…
Glenmark confirms patent challenge for Bendamustine Hydrochloride
This ANDA has been filed from Glenmark's Argentina lyophilized injectable facility